Status:
COMPLETED
Targeted Memory Reactivation During REM Sleep in Patients With Social Anxiety Disorder
Lead Sponsor:
University Hospital, Geneva
Conditions:
Social Anxiety Disorder
Sleep
Eligibility:
All Genders
16-40 years
Phase:
NA
Brief Summary
With this study, the investigators aim to use sleep and dreaming in order to enhance exposure therapy for social anxiety disorder (SAD), by pairing the positive feedback phase of exposure (public talk...
Eligibility Criteria
Inclusion
- Patients with social anxiety disorder (according to DSM-5 criteria and Liebowitz Social Anxiety Scale \> 65)
- aged between 16 and 40 yo
- no current treatment for SAD (cognitive-behavioral therapy, medications)
Exclusion
- mood disorder, psychosis,other anxiety disorder or other mental disorders according to DSM-5 criteria
- sleep disorder (e.g.,insomnia disorder, obstructive sleep apnea syndrome, restless legs syndrome) according to DSM-5 criteria
- use of psychiatric medication
- current treatment for SAD (cognitive-behavioral therapy, medications)
- neurological disease
Key Trial Info
Start Date :
February 18 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 6 2022
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT05261659
Start Date
February 18 2020
End Date
February 6 2022
Last Update
March 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for Sleep Medicine, University Hospitals of Geneva
Geneva, Switzerland, 1225